Improving monitoring of antibiotic resistance in animals
Building AMR monitoring capacity through expanding NGS capabilities
This study is working to help a veterinary lab better track antibiotic-resistant germs that can affect both pets and farm animals, so that pet owners and livestock producers can get better care and management for infections that don't respond to regular antibiotics.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michigan State University NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project ID | NIH-10829110 on NIH RePORTER |
What this research studies
This research aims to enhance the capabilities of the Michigan State University Veterinary Diagnostic Laboratory to monitor antimicrobial resistance (AMR) in pathogens that pose risks to both animal and public health. By expanding next-generation sequencing (NGS) technologies, the laboratory will improve its ability to conduct surveillance on antibiotic-resistant infections in various animal species. The project involves collaboration with national initiatives to combat antibiotic resistance, ensuring that the laboratory can effectively analyze and respond to AMR threats. Patients, particularly pet owners and livestock producers, may benefit from improved diagnostics and management of antibiotic-resistant infections.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include pet owners and livestock producers concerned about antibiotic resistance in their animals.
Not a fit: Patients who do not own animals or are not involved in animal husbandry may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to better detection and management of antibiotic-resistant infections in animals, ultimately protecting public health.
How similar studies have performed: Other research initiatives focused on antimicrobial resistance surveillance have shown success, indicating that this approach is both relevant and necessary.
Where this research is happening
East Lansing, United States
- Michigan State University — East Lansing, United States (Active)
Researchers
- Principal investigator: Dodd, Kimberly — Michigan State University
- Study coordinator: Dodd, Kimberly
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.